Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit neurite outgrowth: a light, epifluorescence, and electron microscopy study.
Proteoglycans influence aging and plasticity in the nervous system. Particularly prominent are the chondroitin sulfate proteoglycans (CSPGs), which are generally inhibitory to neurite outgrowth. During development, CSPGs facilitate normal guidance, but following nervous system injury and in diseases of aging (e.g., Alzheimer's disease), they block successful regeneration, and are associated with axon devoid regions and degenerating nerve cells. Whereas previous studies used non-nervous system sources of CSPGs, this study analyzed the morphology and behavior of sensory (dorsal root ganglia) neurons, and a human nerve cell model (SH-SY5Y neuroblastoma cells) as they contacted nervous system-derived CSPGs, using a variety of microscopy techniques. The results of these qualitative analyses show that growth cones of both nerve cell types contact CSPGs via actin-based filopodia, sample the CSPGs repeatedly without collapse, and alter their trajectory to avoid nervous system-derived CSPGs. Turning and branching are correlated with increased filopodial sampling, and are common to both neurons and Schwann cells. We show that CSPG expression by rat CNS astrocytes in culture is correlated with sensory neuron avoidance. Further, we show for the first time the ultrastructure of sensory growth cones at a CSPG-laminin border and reveal details of growth cone and neurite organization at this choice point. This type of detailed analysis of the response of growth cones to nervous system-derived CSPGs may lead to an understanding of CSPG function following injury and in diseases of aging, where CSPGs are likely to contribute to aberrant neurite outgrowth, failed or reduced synaptic connectivity, and/or ineffective plasticity.
Snow
D M
DM
Department of Anatomy and Neurobiology, University of Kentucky, Lexington, Kentucky 40536-0298, USA. dsnow@pop.uky.edu
Mullins
N
N
Hynds
D L
DL
D000199:Actins / Q000032:analysis / Q000378:metabolism; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D002642:Chick Embryo; D002645:Chickens; D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism / Q000494:pharmacology*; D018920:Coculture Techniques; D005727:Ganglia, Spinal / Q000187:drug effects; D020439:Growth Cones / Q000187:drug effects* / Q000648:ultrastructure; D006801:Humans; D007797:Laminin / Q000494:pharmacology; D008854:Microscopy, Electron; D008856:Microscopy, Fluorescence; D016501:Neurites / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000502:physiology; D009473:Neuronal Plasticity; D009475:Neurons, Afferent / Q000502:physiology; D011554:Pseudopodia / Q000378:metabolism; D051381:Rats; D012583:Schwann Cells / Q000187:drug effects; D013997:Time Factors; D014407:Tumor Cells, Cultured; D014463:Ultrasonography
D000199:Actins; D011508:Chondroitin Sulfate Proteoglycans; D007797:Laminin